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ABSTRACT: PfSUB1, a subtilisin-like protease of the human malaria parasite
Plasmodium falciparum, is known to play important roles during the life cycle of the
parasite and has emerged as a promising antimalarial drug target. In order to provide a
detailed understanding of the origin of binding determinants of PfSUB1 substrates, we
performed molecular dynamics simulations in combination with MM-GBSA free energy
calculations using a homology model of PfSUB1 in complex with diﬀerent substrate
peptides. Key interactions, as well as residues that potentially make a major contribution
to the binding free energy, are identiﬁed at the prime and nonprime side of the scissile
bond and comprise peptide residues P4 to P2′. This ﬁnding stresses the requirement for
peptide substrates to interact with both prime and nonprime side residues of the PfSUB1
binding site. Analyzing the energetic contributions of individual amino acids within the peptide-PfSUB1 complexes indicated that
van der Waals interactions and the nonpolar part of solvation energy dictate the binding strength of the peptides and that the
most favorable interactions are formed by peptide residues P4 and P1. Hot spot residues identiﬁed in PfSUB1 are dispersed over
the entire binding site, but clustered areas of hot spots also exist and suggest that either the S4-S2 or the S1-S2′ binding site
should be exploited in eﬀorts to design small molecule inhibitors. The results are discussed with respect to which binding
determinants are speciﬁc to PfSUB1 and, therefore, might allow binding selectivity to be obtained.
■ INTRODUCTION
Malaria remains one of the most important infectious diseases
worldwide, causing 300−500 million clinical cases and over one
million deaths each year. The disease results from infection
with apicomplexan protozoan parasites of the genus Plasmo-
dium. The most severe form of malaria is caused by infection
with Plasmodium falciparum, but recent alarming reports have
indicated that infections with both Plasmodium vivax and
Plasmodium knowlesi can also be fatal.1,2 Although there are
several antimalarial drugs available, the emerging spread of
multidrug-resistant parasite strains stresses the need to identify
new targets that can be exploited with therapeutic agents.
A promising malarial drug target is a subtilisin-like protease,
named PfSUB1 in P. falciparum, which is central to the
replication of the parasite in human red blood cells (RBC).
Each cycle of replication results in the formation of 16 or more
daughter merozoites. PfSUB1 is thought to trigger a cascade of
proteolytic events that culminate in the release of the
merozoites from the infected RBC (a process called egress)
and in addition is required for maturation of merozoite surface
proteins to enable their invasion of new RBCs.3,4 The potential
of PfSUB1 as a drug target is supported by several ﬁndings.
First, pharmacological inhibition of PfSUB1 blocks egress and/
or reduces the invasion of RBCs by merozoites.4−6 Second, a
peptidyl α-ketoamide based on an authentic PfSUB1 substrate
inhibits PfSUB1 as well as its orthologues in P. vivax and P.
knowlesi.7 This suggests that it should be possible to design
substrate-based compounds that inhibit the enzyme in all three
major human pathogens. Third, several small molecules have so
far emerged as selective inhibitors, including a natural
compound called MRT12113,5,8 covalent inhibitors based on
chloroisocoumarins,6 maslinic acid,9 and a quinolylhydrazone.10
Retesting of maslinic acid using a ﬂuorescence assay, however,
has questioned its activity against PfSUB1 (data not shown),
and the hydrazone class shows a very ﬂat structure−activity
relationship in the 20 μM range.10 Thus, there is still a need to
identify small druglike molecule modulators amenable to
chemical modiﬁcation that inhibit the function of PfSUB1.
Insights into the determinants of binding interactions
between an enzyme and its natural substrates can be exploited
to facilitate the identiﬁcation of small-molecule inhibitors for
therapeutic intervention. Previous identiﬁcation of several
validated physiological substrates have provided some initial
insights into the substrate preference of PfSUB1 (Figure 1)
revealing a strong tendency for hydrophobic amino acids at P4,
no preference at P3, a restriction to small amino acids at P2, a
tendency for amide-containing and acidic amino acids at P1,
and a tendency for hydroxyl-containing and acidic residues at
the prime side positions P1′-P5′.4,5,11 Mutational analysis of
peptide substrates has implied, furthermore, that the P1 to P4
residues are not suﬃcient for substrate binding to PfSUB1,4
Received: December 7, 2012
Published: February 17, 2013
Article
pubs.acs.org/jcim
© 2013 American Chemical Society 573 dx.doi.org/10.1021/ci300581z | J. Chem. Inf. Model. 2013, 53, 573−583
suggesting that prime side residues are required for optimal
substrate recognition. Knowledge about the substrate prefer-
ence, however, does not provide direct insights into the binding
determinants of the PfSUB1 binding site. Important questions
that remain include the following: Which residues of the
PfSUB1 binding site are essential for binding aﬃnity and
should, therefore, be exploited in compound design eﬀorts?
What are the key interactions with known substrates that can be
used to guide the identiﬁcation and optimization of small
molecule inhibitors?
In order to provide a better understanding of the binding
modes and the origin of the binding determinants of PfSUB1
substrates, we have performed molecular dynamics (MD)
simulations in combination with MM-GBSA free energy
calculations of a homology model of PfSUB1 in complex
with diﬀerent deca-peptide substrates (Table 1). The peptides
were chosen based on validated substrates, including members
of the serine-rich antigen (SERA) family and merozoite surface
proteins (MSP). In addition, PfSUB1-peptide complex
structures with sequence variations at the prime side (e.g.,
Ala mutations) were simulated in order to investigate the
stabilizing eﬀect of prime side residues. The present results
extend an initial MD study performed by us where the
formation of hydrogen bonds to the SERA4 peptide substrate
was investigated.7 Here, we have signiﬁcantly extended that
previous analysis by investigating the eﬀect of sequence
variations of PfSUB1-peptide complex structures, by analyzing
key hydrogen bonds formed between peptide substrates and
the PfSUB1 binding cleft, and by investigating energetic
contributions of individual residues to binding. The MD results
provide critical insights into the binding determinants of the
PfSUB1 structure, which are currently being used to guide
structure−activity experiments of peptidic compounds and
which will facilitate future inhibitory compound design eﬀorts
in general.
■ MATERIALS AND METHODS
Preparation of MD Starting Structures. Starting
structures for the MD simulations were derived using a
homology model of the catalytic domain of PfSUB112 and
modeling substrate peptides by superposition of the backbone
coordinates of homologue complexes (PDB codes: 1LW613
and 1MEE14). Side-chain atoms in 1LW6 and 1MEE were kept
whenever possible in order to guide the peptide side-chain
conformations. In more detail: P5-P2 were modeled by using
the corresponding residues in 1LW6 (TIVL) and P1-P5′ were
modeled by using the corresponding residues in 1MEE (D↓
LRYN). Remaining missing atoms in the side-chains were built
by mutation of the corresponding amino acid using tleap from
the Amber 11 package.15 The peptides were then minimized
using MOE in the complex structures using the MMFF94x
force ﬁeld, keeping the receptor structure ﬁxed, and tethering
the heavy atoms with a force constant of 100 kcal/(mol Å2). To
Figure 1. Structural model and substrate speciﬁcity of the active site of PfSUB1. (a) Homology model of a PfSUB1-peptide complex structure used
as starting structure for the MD simulations.7,42 The structural model is in line with the substrate speciﬁcity shown in (b), revealing distinct
hydrophobic S4 and polar S1 pockets, a small uncharged S2 pocket (explaining the restriction to Ala or Gly at P2), and a less distinct S3 pocket. The
latter is common in members of the subtilase family of serine proteases29 resulting in the side-chain of P3 pointing away from the active site toward
the solvent. (b) Sequence logo of the known PfSUB1 peptide substrates4,11 reveals the substrate preference: hydrophobic amino acids at P4 (Ile, Leu,
Val, Thr), no preference at P3, small amino acids at P2 (Ala, Gly), amide containing and acidic amino acids at P1 (Asp, An, Glu, Gln), and hydroxyl-
containing polar and acidic residues at the prime side positions P1′-P5′ (Ser, Thr, Asp, Glu). (c) For comparison, sequence logo of the PfSUB1
peptide substrates used in this study.
Table 1. List of Simulated PfSUB1-Peptide Complex
Structuresa
native sequences
processing site
identity notes
LVSAD↓NIDIS PfSUB1 internal cleavage site
KITAQ↓DDEES SERA4 site 1 most eﬃciently cleaved peptide
EIKAE↓TEDDD SERA5 site 1 variation at P1 and P1′-P5′
KVKAQ↓DDFNP SERA6 site 1 P1′ = D; P3′ not polar
VVTGE↓AISVT MSP1-42 P1′ not polar
prime side variations notes
KITAQ↓ADEES single Ala mutation
KITAQ↓ADAES double Ala mutation
KITAQ↓ADDES double mutation
KITAQ↓AAAAA quintuple Ala mutation
KITAQ↓D
aDownward-pointing arrow denotes the scissile bond.
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avoid terminal charges on the peptides, the N- and C-terminal
residues were capped with acetyl (ACE) and N-methylamine
(NME) groups, respectively.
Setup of MD Simulations. MD simulations of PfSUB1
bound to ten diﬀerent peptide substrates (Table 1) were
performed with the Amber 11 suite of programs15 together with
the ﬀ99SB modiﬁcations16,17 of the Cornell et al. force ﬁeld.18
In all cases, the system was neutralized by adding sodium
counter-ions and solvated in a truncated octahedron box of
TIP3P water molecules,19 forming a solvent shell of at least 11
Å between each face of the box and the solute. The systems
were minimized by 250 steps of steepest descent minimization
followed by 250 steps of conjugate gradient minimization. The
particle mesh Ewald (PME) method20 was used to treat long-
range electrostatic interactions, and bond lengths involving
hydrogen atoms were constrained using the SHAKE
algorithm.21 The integration time step for all MD simulations
was 2 fs, with a direct-space nonbonded cutoﬀ of 9 Å. After
minimization, MD in the canonical ensemble (NVT) was
carried out for 50 ps, during which time the systems were
heated from 100 to 300 K. Harmonic restraints with force
constants of 5 kcal/(mol Å2) were applied to all receptor and
peptide atoms in this step. Subsequent isothermal isobaric
ensemble (NPT)-MD was performed for 50 ps to adjust the
solvent density. Finally, the force constants of the harmonic
restraints on the receptor atoms were gradually reduced to zero
over 250 ps in the NVT ensemble. An additional 50 ps of
unconstrained NVT-MD at 300 K with a time constant of 2.0
ps for heat bath coupling were performed to relax the system
without constraints. The production runs of all simulations
achieved lengths of 50 ns of which snapshots saved at 20 ps
intervals of the last 40 ns were used for analysis of hydrogen
bonds and calculation of eﬀective binding free energies.
Analysis of MD Trajectories. The ‘ptraj’ module of Amber
11 was used for analyzing the root-mean square deviation
(RMSD) between structure pairs, the root-mean square
ﬂuctuations (RMSF) about the mean position of atoms, and
the formation of hydrogen bonds. For RMSD and RMSF
calculations, overall translational and rotational motions were
removed with respect to all heavy atoms of the core region of
the respective PfSUB1-peptide complex structures; i.e. the six
surface-exposed loops were not included (excluded residues:
384−392, 396−411, 520−534, 543−551, 561−574, and 639−
646). RMSD were accordingly calculated for all heavy atoms of
the core region of the respective PfSUB1-peptide complexes.
RMSF values were calculated for the backbone atoms of the
peptide structures.
Hydrogen bonds were deﬁned by a distance cutoﬀ of 3.2 Å
and an angle cutoﬀ of 120°. Hydrogen bonds were only
considered if their occupancies attained > 20% (percent of
simulation time in which the hydrogen bond is formed).
PfSUB1 residue numbering used in this study refers to the P.
falciparum 3D7 sequence (PlasmoDB ID PF3D7_0507500;
previous ID: PFE0370c).
Calculation of Eﬀective Binding Free Energies and
Per-Residue Contributions. MM-GBSA calculations22−24
were carried out following the “single trajectory method”,
where snapshots of the binding partners were extracted from
MD trajectories of PfSUB1-peptide complexes. The single
trajectory method neglects energetic contributions due to
conformational changes but leads to a drastic reduction in the
statistical uncertainty of the free energy components.22 The
basic idea of the MM-GBSA approach is that the free energy of
binding can be calculated by considering only the end points of
the thermodynamical cycle of ligand binding (bound and free
states).
All counterions and water molecules were stripped from the
snapshots and the analysis performed using the MM-PBSA Perl
script provided in the Amber 11 suite of programs.15 The
binding free energy, ΔGbind, can be calculated as
= − −
= Δ + Δ + Δ − Δ
G G G G
E G G T S
bind complex protein ligand
MM GB PB SA/ (1)
where ΔEMM is the gas-phase interaction energy between the
PfSUB1 receptor and the peptide including the electrostatic
and van der Waals energies, ΔGGB/PB and ΔGSA are the
electrostatic and nonpolar contributions to desolvation upon
peptide binding, respectively, and TΔS are the entropy
contributions arising from changes in the degrees of freedom
of the solute molecules, which were not considered here, i.e., all
values reported for the MM-GBSA calculations should thus be
considered as “eﬀective energies” (ΔGEff) rather than free
energies. For comparison, MM-PBSA calculations were also
carried out.
In order to detect hot spot residues, the eﬀective binding
energies were decomposed into contributions of individual
residues using the MM-GBSA energy decomposition scheme
introduced by Gohlke et al.25
MM-GBSA Calculations. For each snapshot, ΔEMM was
calculated based on the ﬀ99SB force ﬁeld17 without applying
any nonbonded cutoﬀ. ΔGGB, the polar contribution to the
solvation free energy, was determined by applying the ‘OBC’
Generalized Born (GB) method (igb = 2) and using mbondi2
radii. ΔGGB/PB calculations are sensitive to the solute dielectric
constant. Following ﬁndings from Hou et al.26 for moderately
charged binding interfaces, as present in the PfSUB1 binding
cleft, the internal dielectric constant was set to 2 and the
external dielectric constant to 80. The eﬀect of the chosen
internal dielectric constant on the predicted binding free
energies was, furthermore, investigated by setting diﬀerent
internal dielectric constants (ein = 1, 2, 3, and 4). The polar
contributions were computed at 100 mM ionic strength (saltcon
= 0.1 M). ΔGSA, the nonpolar contribution to the solvation free
energy, was estimated using the ICOSA method (gbsa = 2) by a
solvent accessible surface area (SASA)-dependent term using a
surface tension proportionality constant of γ = 0.0072 kcal/
(mol Å2) and an oﬀset of 0 kcal/mol. The autocorrelation
function of the free energy was calculated,22 using snapshots
saved at 200 fs intervals of the 11 ns, to determine the ideal
frequency to extract snapshots to avoid analyzing correlated
structures.
MM-PBSA Calculations. ΔEMM was calculated in the same
way as in the MM-GBSA calculation (using the ﬀ99SB force
ﬁeld). ΔGPB was determined by solving the linearized Poisson−
Boltzmann (PB) equation (proc = 2) using Parse radii and a
solvent probe radius of 1.4 Å. A dielectric constant of 2 and 80
for the interior and exterior of the solute was applied,
respectively. The polar contributions were computed at 100
mM ionic strength (istring = 100 mM). ΔGSA was estimated
using the NPOTP method by a solvent accessible surface area
(SASA)-dependent term using a surface tension proportionality
constant of γ = 0.00542 kcal/(mol Å2) and an oﬀset of 0.92
kcal/mol.
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■ RESULTS
In order to investigate the binding mode and the binding
determinants of PfSUB1 substrates, MD simulations of PfSUB1
bound to ﬁve known peptide substrates were carried out in
combination with free energy calculations. The investigated
peptides were LVSAD↓NIDIS (an internal cleavage site of
PfSUB1; scissile bond indicated by a downward-pointing
arrow), KITAQ↓DDEES (SERA4 site 1; the most eﬃciently
cleaved peptide identiﬁed to date), EIKAE↓TEDDD (SERA5
site 1), KVKAQ↓DDFNP (SERA6 site 1), and VVTGE↓
AISVT (MSP1-42). Previous results pointed to the unusual
requirement of PfSUB1 to interact with both prime and
nonprime side residues of the substrate recognition motif.4,7 In
order to further investigate the role of the P1′-P5′ residues,
several sequence variations at the prime side of the KITAQ↓
DDEES peptide were also investigated (Table 1).
Convergence and Stability Examination. The con-
vergence and stability of the simulations were monitored
through the examination of structural and energetic properties,
which included the root-mean-square deviation (RMSD) of
heavy atoms with respect to structures obtained at the end of
the equilibration procedure and the eﬀective free energy during
the MD simulations (Figure 2 and Figure S1 in the Supporting
Information).
RMSD Examination. PfSUB1 contains six surface-exposed
loops that undergo large conformational changes during the
MD simulations. Considering the remaining part of the PfSUB1
receptor structures, including the peptide binding site, the
RMSD for all complex structures initially rises to 3.8 Å during
the ﬁrst 5−10 ns but remains constant for the remainder of the
simulations (Figure 2 a)). The initial structures were manually
modeled, which justiﬁes the longer MD equilibration compared
to those generally found during other MD simulations.
Free Energy Examination. Fluctuations of eﬀective binding
energies for the PfSUB1-peptide complex structures are shown
together with cumulative mean values in Figure 2 b). The
eﬀective energies are quite variable, but the accumulated mean
values become stable for most cases after 10 ns of simulation
time (Figure 2 b)). This is consistent with the RMSD analysis
in Figure 2 a). Thus, the following analysis of binding energies,
binding determinants, and hydrogen bond formation is based
on snapshots obtained after 10 ns of the production runs.
To obtain reliable estimates of binding energies, the
snapshots used for the binding free energy evaluation must
be independent and the averaged free energy values must be
converged. Encouragingly, both aspects are fulﬁlled: First, as
the correlation time for the “eﬀective energies” for all systems is
about 1−2 ps, the snapshots used for the binding free energy
evaluation, which were extracted at time intervals of 20 ps,
should be independent.22 Second, the plots in Figure 2 b)
Figure 2. Convergence and stability examination for MD simulations of PfSUB1-peptide complex structures. (a) Time series of RMSD values of
PfSUB1-peptide complexes are shown with respect to structures obtained at the end of the equilibration procedure. (b) Eﬀective binding free
energies (green) are shown together with accumulated mean values (red) for PfSUB1-peptide complexes. (c) Atomic ﬂuctuations (RMSF) of
peptide backbone atoms during MD trajectories of the respective PfSUB1-peptide complex structure. Color-coding of PfSUB1-peptide complexes is
as in (a). Vertical lines in (a) and (b) indicate the time after which snapshots were extracted for further analysis. Equivalent plot for PfSUB1-peptide
complex structures with sequence variations at the prime side of the KITAQ↓DDEES peptide are shown in Figure S1 in the Supporting Information.
Table 2. Binding Free Energies and Selected Individual Energy Contributions of PfSUB1-Peptide Complex Structuresa
sequence processing site identity ΔGEff ΔGnonpolar ΔGGBELE
LVSAD↓NIDIS PfSUB1 −89.6 ± 0.1 −94.6 ± 0.1 5.0 ± 0.1
KITAQ↓DDEES SERA4 site 1 −79.1 ± 0.2 −86.3 ± 0.2 7.2 ± 0.1
EIKAE↓TEDDD SERA5 site 1 −77.8 ± 0.2 −84.1 ± 0.2 6.3 ± 0.1
KVKAQ↓DDFNP SERA6 site 1 −91.8 ± 0.1 −102.9 ± 0.1 11.2 ± 0.1
VVTGE↓AISVT MSP1−42 −95.3 ± 0.1 −104.1 ± 0.1 8.8 ± 0.1
aAll values are given in kcal/mol (±standard error of the mean); calculated for trajectory range 10−50 ns. ΔGEff = sum of the gas-phase interaction
energy and the electrostatic and nonpolar contributions to desolvation upon peptide binding (ΔGEff = ΔGMM + ΔGGB + ΔGSA). ΔGnonpolar = sum of
van der Waals contribution from the molecular mechanics force ﬁeld and the nonpolar contribution to the solvation free energy (ΔGnonpolar =
ΔGMM‑VDW + ΔGGBSUR). ΔGGBELE = sum of electrostatic energy as calculated by the molecular mechanics force ﬁeld and the electrostatic contribution
to the solvation free energy (ΔGGBELE = ΔGMM‑ELE + ΔGGB).
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indicate rather stable time series for eﬀective energies for the
last 40 ns implying that the obtained averaged values are
converged. This is supported by a low standard error for the
calculated mean energies of ∼0.2 kcal/mol (Table 2). Thus,
there was no need to extract snapshots more frequently from
the trajectories.
Overall, the calculated eﬀective energies of complex
formation amount to high negative values (e.g., for the
KITAQ↓DDEES PfSUB1-peptide complex to −79.1 ± 0.2
kcal/mol (Table 2)) indicating that favorable protein-peptide
complexes are formed. The calculated values, however,
overestimate the binding free energy which can be partly
explained due to two missing contributions: the lack of entropic
contributions, which can be expected to be unfavorable in the
case of the ﬂexible peptides; and the lack of energetic
contributions due to conformational changes, which were not
considered here because of the use of the single trajectory
approach.
A previous study from Hou et al.26 showed that MM-PBSA
performed better in calculating absolute binding free energies
but that MM-GBSA performed better in calculating relative free
energies. For comparison, eﬀective energies were also calculated
by the MM-PBSA approach. The predicted values resulted in
general in lower eﬀective energy values (by ca. −17 kcal/mol)
but did not change relative binding free energies compared to
the MM-GBSA approach (Table S1 in the Supporting
Information). Considering in addition the computational
eﬃciency of the MM-GBSA approach, we decided to calculate
the free energy decompositions using the MM-GBSA approach.
Hydrogen Bonds Formed via the Peptide Backbone
Include P4-P2′. To seek initial insights into the binding
determinants of the PfSUB1-substrates, we investigated hydro-
gen bonds formed between PfSUB1 and the simulated peptide
substrates along the MD trajectories (Figures 3 and 4). The
analysis shows that in at least four of the ﬁve peptide complexes
very strong canonical backbone hydrogen bonds (with an
occupancy of at least 60%, indicated in orange and red; Figure
3) are formed between the amino and carbonyl group of P4
and the corresponding backbone groups of Gly467, between
the amino group of P2 and the carbonyl group of Lys465, and
between the amino group of P1 and the carbonyl group of
Ser490 as well as between the amino group of P2′ and Asn603
in the S2′ pocket (Figure 3). Further strong canonical
hydrogen bonds are formed, in three out of the ﬁve peptide
complexes, between the amino and carbonyl group of P3 and
Ser492 and between the carbonyl group of P1 and either the
amino group of Thr605 or Ser606 (Figure 3). Interestingly,
strong backbone-backbone (canonical) hydrogen bonds formed
with P3 are present in peptides with a Val (V) at P4 but not
with an Ile (I) at that position. The only backbone component
of the nonprime segment that does not form hydrogen bonds
at all is the carbonyl group of P2, which points toward the
solvent during the course of all simulations.
The identiﬁcation of strong canonical backbone hydrogen
bonds formed between P4-P2′ and the PfSUB1 binding site is
in agreement with restricted ﬂuctuations of the P5-P2′ residues,
whereas the prime side residues P3′-P5′ undergo pronounced
conformational changes (Figure 2 c)) in the case of most of the
simulated PfSUB1-peptide complexes. Only PfSUB1-peptide
complexes LVSAD↓NIDIS and KVKAQ↓DDFNP have re-
stricted ﬂuctuations of the P3′-P5′ residues, which can be
explained by strong hydrogen bonds formed by these residues.
Figure 3. Scheme of hydrogen bonds formed between PfSUB1 and
peptide substrates along the MD trajectories. The peptide orientation
is shown from N- to C-terminus left-to-right and so is opposite to the
orientation shown in (Figure 1). Very strong hydrogen bonds are
boxed in red (occupancy of 80−100%) and orange (occupancy of 60−
80%); strong hydrogen bonds are boxed in green (occupancy of 40−
60%). Residues of the PfSUB1 binding site are labeled in bold or italics
depending on whether the hydrogen bond is formed with a backbone
group (bold) or a side-chain group (italics) of PfSUB1. In (b) an
intramolecular hydrogen bond formed between the amine group of P1
and the carbonyl group of P3 is indicated as dashed line. In the case of
residues which form more than one hydrogen bond, the coloring is
based on the stronger hydrogen bond. In the case of the ammonium
functionality of Lys465, the occupancy values of formed hydrogen
bonds are added up and the box accordingly colored. The
identiﬁcation of strong hydrogen bonds based on occupancy values
is supported by the analysis of the per-residue decomposition of
relative free energies of the PfSUB1 binding site. Considering the
backbone and side-chain part of the per-residue contributions
separately revealed that for almost all of the identiﬁed hydrogen
bonds the favorable electrostatic interaction as calculated by the
molecular mechanics force ﬁeld (ΔGMM‑ELE) outbalances the
unfavorable electrostatic contribution due to desolvation (ΔGGB)
(exceptions are marked via *), respectively.
Journal of Chemical Information and Modeling Article
dx.doi.org/10.1021/ci300581z | J. Chem. Inf. Model. 2013, 53, 573−583577
Hydrogen Bonds Formed via Peptide Side-Chains
Include P1 and P1′. In addition, stabilizing hydrogen bond
interactions are formed by the peptide side-chains, but these
interactions are very dependent on the peptide sequence. The
only two peptide side-chains that form stable hydrogen bonds
with the PfSUB1 binding site are residue positions P1 and P1′
(Figure 4).
Hydrogen bonds formed via the P1 side-chains include most
commonly the backbone of Asn520 (Figure 3 a, b, and e) but
also occasionally the backbone of Ala518 (Figure 3 d) and the
side-chains of Ser492 and Ser517 (Figure 3 a and d). Hence, it
is of note that the polar P1 side-chain forms strong side-chain
hydrogen bonds only in the case of the LVSAD↓NIDIS and
KVKAQ↓DDFNP peptides (Figure 3 a and d). This was
initially considered surprising given the presence of three
spatially adjacent Ser residues in the polar S1 pocket (Ser517,
Ser519, and Ser492). We conclude that peptide binding is
preferentially mediated by stabilizing hydrogen bonds between
the P1 side chain and the backbone group of Asn520 and, in
the case of the KITAQ↓DDEES peptide, another internal
hydrogen bond with the carbonyl backbone group of P3. An
interesting ﬁnding in this context is that the only investigated
peptide with an Asp (D) at P1 does form stabilizing hydrogen
bonds with the hydroxyl groups of Ser492 and Ser517.
In contrast to the P1 residue, the P1′ residues form in general
strong polar side-chain interactions (Figure 3 b, c, and d). In
the case of the KITAQ↓DDEES (Figure 3 b) and KVKAQ↓
DDFNP (Figure 3 d) peptides, these interactions are salt
bridges formed between an Asp (D) and Lys465 in the S2
pocket.
Identiﬁcation of Hot Spots by MM-GBSA Free Energy
Decomposition. We next analyzed the energetic contribu-
tions of individual amino acids to PfSUB1-peptide complex
formation to search for the dominant factors that dictate
binding speciﬁcity of peptide substrates. For this, calculated
binding free energies were decomposed on a per-residue level
using the MM-GBSA approach in Amber 1115 and the single
trajectory method.25 Calculations of this type not only
rationalize molecular recognition processes but also can guide
the identiﬁcation of small inhibitor molecules that mimic the
determinants of binding of protein−protein complexes (hot
spots).27 Similarly, we expected that hot spots of PfSUB1-
peptide complexes are equally important for small molecule
binding to PfSUB1.28
Per-Residue Contributions of Peptides to Binding
Free Energies Identiﬁes P1 and P4 To Be the Main “Hot
Spot” Residues. The decompositions of relative free energies
revealed that among all ﬁve investigated peptide substrates, the
most favorable interactions are formed by peptide side-chain
position P4 (⌀ΔGEff = −8.2 ± 0.5 kcal/mol) and P1 (⌀ΔGEff =
−6.4 ± 1.4 kcal/mol) (Table S2 in the Supporting
Information).
In the case of P4, this is consistent with the importance of P4
residues in substrate recognition by subtilases in general29 and
agrees with an experimental mutation study on the LVSAD↓
NIDIS peptide, where substitution of P4 Val (V) to Ala (A)
had the greatest eﬀect on substrate cleavage eﬃciency.4 The
large contribution of P4 to the binding free energy may be
attributed to the van der Waals contribution and the nonpolar
part of solvation free energy (Tables S3−S7 in the Supporting
Information), which is not surprising given the highly
hydrophobic nature of the S4 pocket.
In the case of P1, our earlier study (Koussis et al.) indicated
that some ﬂexibility is tolerated at P1 but that Asp (D), Ser (S),
and Ala (A) are cleaved with the best eﬃciency.4 Given the
tolerance of P1 to accommodate diﬀerent polar and small
hydrophobic side-chains, the ﬁnding that P1 has the second
greatest eﬀect on the binding aﬃnities is an unexpected
outcome of this study. The large contribution of the P1 residue
to complex stability does not arise from electrostatic
interactions as one might have expected given the ﬁnding of
strong hydrogen bonds formed by the P1 side-chain (Figure 4).
An explanation is that in the case of P1, the favorable
electrostatic interaction as calculated by the molecular
mechanics force ﬁeld (ΔGMM‑ELE) is canceled by the
unfavorable electrostatic contribution due to desolvation
(ΔGGB). In contrast, the van der Waals contribution
(ΔGMM‑VDW) and the nonpolar part of solvation free energy
(ΔGGBSUR) contributes favorably to binding (Tables S3−S7 in
the Supporting Information). The decomposition analysis
suggests, furthermore, that having a large side-chain at P1,
such as in Gln (Q) and Glu (E), increases the binding aﬃnity
toward PfSUB1 as compared to the smaller Asp (D). This is in
line with the substrate preference of known substrates (Figure
1).
Considering only those residues whose contributions to the
eﬀective energy ΔGEff are ≤ −4 kcal/mol (Figure 5), it
becomes apparent that the distribution of further hot spot
residues (as indicated in this study) varies depending on the
investigated peptide sequence. P2 and P1′ have a key
contribution to binding in three of the ﬁve investigated peptide
substrates, while P5, P3, and P2′ have a key contribution to
binding in two of the ﬁve peptide substrates. Based on the
decomposition results, it seems to be beneﬁcial to have an Ala
(A) at P2 over a Gly (G). At P1′ an uncharged residue (e.g., A
or T) seems to be favorable over a charged Glu (D) (Figure 5;
see Discussion and Conclusion for further discussion).
Eﬀect of the Internal Dielectric Constant on the Predicted
Binding Free Energies. MM-GBSA predictions are quite
sensitive to the choice of the internal dielectric constant ein,
and therefore this parameter should be carefully chosen
Figure 4. Summary scheme of hydrogen bonds formed between
PfSUB1 and peptide substrates along the MD trajectories. The
number of substrate peptides which form strong hydrogen bonds
(occupancy > 40% as shown in Figure 3) are depicted as bar plots in
(a) for hydrogen bonds formed with the peptide backbone and in (b)
for hydrogen bonds formed with the peptide side-chains. In (a)
hydrogen bonds formed with the backbone carbonyl group (left bar
plot) are distinguished from those formed with the backbone amino
group (right bar plot). Residues which form hydrogen bonds in at least
four investigated substrates are depicted in red.
Journal of Chemical Information and Modeling Article
dx.doi.org/10.1021/ci300581z | J. Chem. Inf. Model. 2013, 53, 573−583578
according to the binding site characteristics.26 For hydrophobic
binding interfaces, a low internal dielectric constant (ein = 1)
can be recommended, while for highly charged binding
interfaces, where a strong change in polarization occurs upon
binding, higher values (ein = 4) should be used.
26 Following
ﬁndings from Hou et al.26 for moderately charged binding
interfaces (2−3 charged residues), as present in the PfSUB1
binding cleft (Arg600 (P3′), Lys465 (P1′), Arg468 (S5)), ein
was set to 2. However, we have also tested the eﬀect of ein on
the predicted binding free energies by setting diﬀerent ein
constants (1, 2, 3, and 4).
These analyses revealed that increasing ein results in lower
eﬀective free energies but that the trend of calculated binding
free energies remained the same for the investigated PfSUB1-
complex structures (Table S1 in the Supporting Information).
Similarly, the eﬀect of increasing ein on the per-residue
contribution to the eﬀective binding energy of PfSUB1-peptide
complexes revealed that the contribution of hydrophobic
residues barely changed (the contribution of 94% of the
hydrophobic residues changed only with a standard deviation of
< 0.5 kcal/mol). However, the contribution of charged residues
increased signiﬁcantly (the contribution of 55% of the charged
residues increased with a standard deviation of > 1.0 kcal/mol).
The reason for this was that the shielding eﬀect of larger ein
values on the favorable electrostatic interaction as calculated by
the molecular mechanics force ﬁeld (ΔGMM‑ELE) was lower than
the eﬀect on the unfavorable electrostatic contribution due to
desolvation (ΔGGB) (Tables S3−S7 in the Supporting
Information). In the case of the analyzed PfSUB1-complex
structures, this resulted in a relative larger energy contribution
of the charged P1′ residues in the case of the ein = 3 and ein = 4
analysis, which can be explained by strong polar interactions
formed with the nearby Lys465 residue and the eﬀect described
above. Encouragingly, in all settings, the most favorable
interactions are formed by peptide residues P4 and P1 which
demonstrates the robustness of the main results.
Sequence Variations at the Prime Side. Motivated by the
ﬁnding that the prime side residues might be important for
optimal substrate recognition,4,7 several sequence variations at
the prime side of the KITAQ↓DDEES peptide were simulated
by changing individual residues to Ala (A) as well as removing
the P2′-P5′ prime part (Figures S1 and S2 in the Supporting
Information). The results obtained seem to contrast with the
suggested role of acidic amino acids at the prime side for
binding speciﬁcity: mutating P1′ to Ala did not change the
energy contribution of P1′. In contrast, removing the P2′-P5′
residues reduced the contribution of P1′ (Figure S2). The latter
is in agreement with the high ﬂuctuations of P1′ in the
KITAQ↓D peptide (Figure S1). Overall, these results point to
the importance of the backbone-backbone hydrogen bonds
formed by P2′ (Figure 3 and 4) to ensure the stabilizing role of
P1′.
Per-Residue Contributions of the PfSUB1 Binding Site
to Binding Free Energies Identiﬁes Four Cluster of Hot
Spot Residues. The MM-GBSA calculations identify, in all
peptide-PfSUB1 complex structures, four subsites whose energy
patterns make a major contribution to the binding free energy
(Figure 6). These “hot spot” regions include, in at least four of
the ﬁve investigated PfSUB1-peptide structures, PfSUB1
residues Phe491, Leu469, and/or Phe493 (S4 pocket),
Lys465 and Leu466 (lower rim of the PfSUB1 binding site
cleft; forming S1′ and the lower part of the S2−S4 pockets),
Ser492 and/or Asn520 (S1 pocket), and Asn603 (S2′ pocket).
This is in line with the hydrogen bond analysis and energy
decompositions of peptide structures above. The hydrogen
bond analysis identiﬁed Lys465 and Asn603 as forming strong
hydrogen bonds with the backbone groups of P2 and P2′,
respectively, and Asn520 as forming strong hydrogen bonds
with the side-chain group of P1. The energy decompositions of
peptide structures identiﬁed, furthermore, that peptide residues
P4 and P1 dominate binding.
■ DISCUSSION AND CONCLUSIONS
In order to enhance our understanding of the binding modes
and the origin of binding determinants of PfSUB1 substrates,
molecular dynamics (MD) simulations were performed and
analyzed in combination with free energy calculations. The
motivation of this study was to address the following questions:
Which residues of the PfSUB1 binding site are essential for
binding aﬃnity and should, therefore, be exploited in
compound design eﬀorts such as docking experiments? What
are the key interactions with known substrates that can be used
to guide the identiﬁcation and optimization of small molecule
inhibitors?
Which Residues Are Essential for Binding Aﬃnity?
The analysis of hydrogen bonds formed along the MD
trajectories indicated that, overall, a large number of canonical
backbone hydrogen bonds are formed between peptide residues
P4-P2′ and the PfSUB1 binding site cleft. This is consistent
with the outcome of the free energy decompositions, which
revealed that, in general, peptide residues P4 and P2-P1′ have
the largest contribution to the eﬀective free energy. This ﬁnding
stresses the requirement of peptide substrates to interact with
both prime and nonprime side residues of the PfSUB1 binding
Figure 5. Per-residue contribution to the binding eﬀective energy of
PfSUB1-peptide complexes are depicted as bar plots. Per-residue
contributions were calculated by the MM-GBSA decomposition
method. Residues whose contributions to the eﬀective energy ΔGEff
≤ −4 kcal/mol are depicted in red. The backbone and side-chain
contributions to the eﬀective free energy are indicated by partitioning
the bar plots. The areas at the top of the bar plots correspond to the
backbone and the areas at the bottom correspond to the side-chain
contributions, respectively. The per-residue contributions were
calculated by applying the MM-GBSA decomposition approach to
MD trajectories of PfSUB1 in complex with ﬁve substrate peptides
(red labels). The distribution of hot spot residues (ΔGEff ≤ −4 kcal/
mol) along the investigated substrates is shown in the lower right
panel. Repeating the analysis for the ﬁrst and second half of the
trajectory resulted in the same pattern of per-residue contributions.
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site as indicated before.4,7 Among the peptide residues, the
most favorable interactions are formed by residues P4 and P1.
Encouragingly, this result was obtained independent of the
choice of the internal dielectric constant. The two peptide
residues are, thus, potentially the main hot spot residues in the
PfSUB1 substrates. The free energy decomposition revealed,
furthermore, that van der Waals interactions and the nonpolar
part of solvation free energy dictate the binding strength of the
peptides, whereas the binding speciﬁcity is determined by
electrostatic interactions and the polar part of solvation free
energy (Table 2; Table S8 in the Supporting Information).
Similar ﬁndings with respect to the binding determinants were
found for other complex structures.30
The present ﬁnding of P4 and P1 to be the most important
residues for the interaction with PfSUB1 agrees partly with a
former study on a PcFK1-PfSUB1 complex model.31 Based on
the number of interacting residues and a free energy
decomposition also using the MM-GBSA approach, the
residues P2 and P1 were found to be the most important
residues for the interaction between PfSUB1 and the YVPAQ↓
NPCCR loop region in PcFK1.31 Several reasons could explain
the diﬀerences to the current study, including the fact that
diﬀerent peptide sequences were investigated and that the latter
analysis was based on a much shorter simulation trajectory.
Which Residues Are Essential for Binding Speciﬁcity
and Selectivity? For most members of the S8A subfamily of
subtilisins, of which PfSUB1 is a member, enzyme speciﬁcity is
primarily dictated by interactions of the P1-P4 residue side-
chains with the corresponding S1-S4 pockets.29 The most
obvious diﬀerence between PfSUB1 and other known members
of the S8A subfamily is the small S2 pocket,7 as it is delimited
by a side-chain in PfSUB1 (Lys465) but is a Gly in most other
S8A subfamily members. This explains not only the restriction
to small residues at the P2 position but also might be exploited
in the design of selective peptide inhibitors; larger S2 pockets
will lose favorable van der Waals and other interactions formed
in the small S2 pocket in PfSUB1.32 In line with this argument,
P2 makes a major contribution to the eﬀective binding energy
(ΔGEff ≤ −4 kcal/mol in three of the ﬁve substrates).
The analysis of hydrogen bonds revealed that in the case of
the KITAQD↓DEESS and KVKAQ↓DDFNP peptides strong
salt bridges are formed between the side-chain keto group of
the P1′ residue and the side-chain ε-amino group of Lys465 in
the S2 pocket. The impact of the salt bridges formed with
Figure 6. Per-residue contribution to the binding eﬀective energy of the PfSUB1 binding site bound to diﬀerent peptide substrates. The per-residue
contributions were calculated by applying the MM-GBSA decomposition approach to MD trajectories of PfSUB1 in complex with (a) LVSAD↓
NIDIS, (b) KITAQ↓DDEES, (c) EIKAE↓TEDDD, (d) KVKAQ↓DDFNP, and (e) VVTGE↓AISVT. The per-residue contributions are mapped
onto the starting structures of the simulations using a color code with a linear scale. Residues whose contributions to the eﬀective free energy ΔGEff
≤ −2 kcal/mol (Table S9 in the Supporting Information) are labeled.
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Lys465 in these two peptides is supported by individual energy
contributions to the binding free energy: Favorable electrostatic
interactions, as calculated by the molecular mechanics force
ﬁeld (ΔGMM‑ELE), outweigh the unfavorable electrostatic
contribution due to desolvation (ΔGGB) (Figure 3). This was
true independent of the choice of the internal dielectric
constant. To ensure stabilizing and selective interactions with
the Lys465 residue, it seems, thus, to be beneﬁcial to have an
Asp (D) at the P1′ position of substrate based inhibitors.
Another region that might be exploited in the design of
selective inhibitors is the S1 pocket, which is characterized in
PfSUB1 by a cluster of Ser residues, i.e. Ser492, Ser517, and
Ser519, which correspond to Gly127, Ala152, and Gly154 in
bacterial subtilisin BPN′ structures (PDB code 1SBT). Our
analysis revealed that in three of the ﬁve investigated peptides
no stabilizing hydrogen bonds are formed between the peptide
substrates and the side-chains of these residues. This indicates
that the S1 pocket might not be a good subpocket to achieve
binding selectivity. The only exception seems to be the aspartic
acid (D) in the LVSAD↓NIDIS complex structure, which forms
stabilizing hydrogen bonds with two of these serine residues.
Which Residues of the PfSUB1 Substrate-Binding
Groove Should Be Exploited in Compound Design
Eﬀorts? The identiﬁcation of binding “hot spots” in receptor
structures can provide a knowledge-driven design of small
inhibitor molecules by guiding the selection of the binding site
used for docking studies27 or by prioritizing points in
pharmacophoric queries.33 The identiﬁed hot spots residues
of the PfSUB1 binding site not only are dispersed over the
entire binding but also form four clusters of hot spot residues:
S4 pocket, lower rim of the PfSUB1 binding site cleft, S1
pocket, and S2′ pocket. The distribution of residues, which
make the major contribution to the binding free energy,
suggests that the subpockets S4-S2 might be the most
promising binding sites, e.g., for docking studies. However,
this would disregard the possibility to use the side-chain keto
group of P1′ to achieve selectivity versus other serine proteases.
Thus, targeting the S1-S2′ binding subpockets should also be
exploited in compound design eﬀorts of small molecules.
Overall, the spread of hot spot residues in the PfSUB1 binding
site indicate that, although PfSUB1 has some potential as a drug
target, it is also a diﬃcult target.
Implication for Structure−Activity Experiments. Pep-
tides that are most eﬃciently recognized and cleaved can be
linked to inhibitory groups to generate speciﬁc inhibitors.34 In
line with this strategy, we published recently the capacity of N-
acetylated peptidyl derivates of PfSUB1 substrates to inhibit
SUB1 from the human malaria pathogens P. falciparum, P.
vivax, and P. knowlesi.7 In agreement with the free energy
calculation presented in this study, a terminal carboxylic acid
extension in the peptidyl α-ketoamide KS466 (designed to
mimic P1′ interactions with PfSUB1) increased the inhibitory
activity by about 2−6-fold.7 The analysis of hydrogen bonds
indicated that the backbone-backbone hydrogen bonds formed
by P2′ might be necessary to ensure the stabilizing role of P1′.
By combining an α-ketoamide functionality with the peptide, a
reversible covalent bond with the hydroxyl side-chain of the
catalytic serine of PfSUB1 is formed.7 In such a case, it can be
expected that the P1′ moiety in a hexapeptide (P5-P1′) forms
the same stabilizing interactions as observed for the simulated
deca-peptide substrates (P5-P5′). The results obtained from the
MD simulations suggest, furthermore, that the P5 residue might
not be necessary to achieve strong binding. Corresponding
structure activity experiments are currently under way for the α-
ketoamide peptide structure.
What Are Key Interactions (Binding Determinants) of
Known Substrates Which Can Be Used To Guide the
Identiﬁcation and Optimization of Small Molecule
Inhibitors? Previously validated substrates have provided the
ﬁrst insights into the substrate preference of PfSUB1 (Figure 1)
revealing, e.g., that P1 has a preference for amide containing
and acidic amino acids. The decomposition of eﬀective energy
in this study has extended our knowledge of the binding
determinants by revealing I) that P1 is a potential hot spot
residue and II) that the large contribution of P1 to the binding
free energy is driven by van der Waals interactions and the
nonpolar part of solvation energy; i.e. in the case of the P1
residue, favorable electrostatic interactions formed by hydrogen
bonds are canceled by unfavorable electrostatic contribution to
desolvation (independent of the choice of the internal dielectric
constant). Thus, having a small hydrophobic moiety in S1 or
changing the amide group to a less polar group might be
favorable for binding.
Role of Prime Side Residues. The analysis of hydrogen
bonds and free energy decomposition identiﬁed P1′ as playing
a key role for peptide stabilization. However, the tendency of
PfSUB1 substrates to contain hydroxyl-containing and acidic
residues at the prime side positions P1′-P5′4,5,11 suggests that
further prime side residues might form stabilizing interactions.
One reason that, e.g., potential hydrogen bonds formed by P2′-
P5′ are not found to be stable along the present MD
trajectories might be that, in the native PfSUB1-substrate
complex, the investigated (inhibitor) peptides can be expected
to be part of a surface loop of a globular protein (such as in
homologous complex structures, e.g., PDB code 1MME). The
protein−protein complex forces the investigated peptide loop
region into a bent shape protruding out of the active site,
whereas further stable hydrogen bonds might be formed by the
prime side residues P3′-P5′ (e.g., P3′ with Lys465 or Tyr427;
suggested based on the starting model structure). In the course
of most of the PfSUB1-peptide trajectories the P3′-P5′ residues
undergo enhanced ﬂuctuations (Figure 2c), thereby binding
only occasionally for a short period of time to diﬀerent regions
of the PfSUB1 structure (either protruding out of the active site
or extending along the S′ pockets). This explains partly why
strong hydrogen bonds as well as hot spot residues are
identiﬁed to comprise peptide residues P4-P2′ but not P3′-P5′.
The goal of the present study was, however, not to investigate
protein−protein complex structures but to get insights into the
binding determinants of PfSUB1 that can be transferred to
small molecule binding. For this objective, simulating PfSUB1-
peptide complex structures was more insightful in our opinion.
Summing up. The present study enhanced our under-
standing of the binding determinants of peptide substrates to
PfSUB1. The results are currently being used to guide
structure−activity experiments of the α-ketoamide peptide
structure described in ref 7. It is encouraging that, although the
present study is based on a homology model of PfSUB1, the
results obtained are in line with the experimental data obtained
so far. This indicates that, in the absence of a crystal structure,
the use of homology models in combination with MD and
MM-GBSA free energy calculations can provide critical insights
into the origin of binding determinants. We expect that the
insights obtained in this study will facilitate compound design
eﬀorts against a promising antimalarial drug target.
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The present study also underlines that using MM-GBSA
calculations in order to estimate absolute binding free energies
remains diﬃcult. However, free energy calculations can still be
useful in practical applications even with a considerable level of
inaccuracy,35 and a number of successful applications to various
systems have been reported.36,37 A more comprehensive
discussion about potential assets and drawbacks of the MM-
GB/PBSA approach in comparison with other free energy
methods can be found elsewhere.36,38,39 The success of the
MM-GBSA approach is quite sensitive to simulation protocols,
such as the sampling strategy to generate snapshots, the
simulation length, the choice of the internal dielectric constant,
the way the entropic contribution is included, etc.26,36,40 As no
experimental binding aﬃnity values are currently available for
PfSUB1 substrates, it was not possible to experimentally justify
the used simulation protocol, and, thus, the parameters used in
this study were guided by the literature (e.g., the internal
dielectric constant ein was set to 2 as recommended for
moderately charged binding interfaces as present in
PfSUB1).22,26
To establish nevertheless the eﬀect of ein on the predicted
binding free energies, diﬀerent ein constants (1, 2, 3, and 4)
were tested. In agreement with a previous report,41 these tests
showed that the absolute value of the electrostatic binding free
energy varies inversely with the value of the dielectric constant
but that the main results are not aﬀected (i.e., the most
favorable interactions were formed in all settings by peptide
residues P4 and P1). However, by increasing ein, the
contribution of charged residues increased signiﬁcantly and
resulted, e.g., into a relative larger contribution of the P1′
residues in the case of the KITAQ↓DDEES and KVKAQ↓
DDFNP peptides (Figure S3 in the Supporting Information).
This shows that an adequate choice of the internal dielectric
constant for a speciﬁc binding pocket might be especially
critical if one aims to understand the determinants of binding of
charged residues.
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